No. AR PL HD Year Citation Title 1st author
92 X 2021 Sci Rep 11(1):22694 (2021) Preparations from selected cucurbit vegetables as antiplatelet agents A Rolnik
91 X 2021 Thromb J 19(1):88(2021) Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System Y Oda
90 X X X 2021 Int. J. Mol. Sci. 22(16), 8605 (2021) The Use of Total Thrombus Formation Analysis System as a Tool to Assess Platelet Function in Bleeding and Thrombosis Risk—A Systematic Review J Sikora
85 X 2021 J Clin Med 10(5):1024 (2021) Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension A Gąsecka
89 X 2021 Sci Rep 11(1):11472(2021) Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey M Shimamura
88 X X 2021 Acute Med Surg 8(1):e648(2021) Influence of high‐dose antithrombin on platelet function and blood coagulation T Miike
87 X 2021 J Functional Foods 80, 104438(2021) Anti-platelet activity of phytocompounds in various dandelion organs in human whole blood model in vitro B Lis
86 X 2021 Int J Mol Sci 22(6):3282(2021) Anti-Platelet Properties of Phenolic and Nonpolar Fractions Isolated from Various Organs of Elaeagnus rhamnoides (L.) A. Nelson in Whole Blood B Skalski
83 X 2021 Biomed Pharmacother 137, 111395(2021) Multidirectional effects of saponin fraction isolated from the leaves of sea buckthorn Elaeagnus rhamnoides (L.) A. Nelson M Juszczak
79 X 2021 Platelets 1-5(2021) The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions KL Zheng
78 X 2021 Thromb Haemost Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study S Ghirardello
72 X X 2020 Pol Arch Intern Med 130(12),p1114-1117(2020) Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome? K Ożegowska
71 X 2020 J Clin Med 9(8):2636(2020) Advances in Platelet Function Testing-Light Transmission Aggregometry and Beyond JL Blanc
69 X X 2020 Pediatr Int (2020) A microchip flow-chamber assay screens congenital primary hemostasis disorders Y Nakajima
67 X X 2020 Kardiol Pol 78(7-8),p667-673(2020) New methodological approaches for assessing thrombus formation in cardiovascular disease K Hosokawa
66 X 2020 J Pediatr S0022-3476(20),p30726-30735(2020) Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease N Tsujii
65 X 2020 Br J Haematol 191(1), e7-e10(2020) Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System in Comparison to the Platelet Function Analyser in Subjects With Primary Haemostatic Defects J Charpy
62 X X 2020 Front Vet Sci 7:307(2020) A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis T Iwanaga
60 X X 2020 Circ J 84(6),p975-984(2020) Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention S Kikuchi
59 X 2019 Haematologica 235549(2019) Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab K Sakai
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.